Waypoint Capital Holdings is a regulated fund management group specialized in financial and investment services. It was created with the objective of managing the portfolio of the Bertarelli family, whose capital base had been built by three generations growing and nurturing Serono into a global biotechnology and pharma leader. Headquartered in Geneva, with offices in London, Jersey, Boston and Luxembourg, Waypoint is active in life sciences and asset management and can offer services to professional, institutional and sophisticated clients.